Insulin glargine: A systematic review of a long-acting insulin analogue
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (6), 1541-1577
- https://doi.org/10.1016/s0149-2918(03)80156-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Physiological insulin replacement in type 1 diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 2001
- Recombinant DNA Technology in the Treatment of Diabetes: Insulin AnalogsEndocrine Reviews, 2001
- Rapid and Long-Acting Analogues as an Approach to Improve Insulin Therapy: An Evidence-Based Medicine AssessmentCurrent Pharmaceutical Design, 2001
- Basal Insulin Therapy in Type 2 DiabetesDiabetes Care, 2001
- Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.Diabetes, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- INTENSIVE TREATMENT OF TYPE 1 DIABETESMedical Clinics of North America, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Physiologic Replacement of InsulinNew England Journal of Medicine, 1989
- The Action Profiles of Human NPH Insulin PreparationsDiabetic Medicine, 1989